Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Almirall Total Liabilities (Quarterly) : 947.80M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 947.80M |
| March 31, 2016 | 1.374B |
| December 31, 2015 | 1.143B |
| September 30, 2015 | 1.221B |
| June 30, 2015 | 1.218B |
| March 31, 2015 | 1.230B |
| December 31, 2014 | 1.434B |
| September 30, 2014 | 1.092B |
| June 30, 2014 | 1.192B |
| March 31, 2014 | 1.226B |
| December 31, 2013 | 1.200B |
| September 30, 2013 | 535.64M |
| June 30, 2013 | 510.18M |
| March 31, 2013 | 505.81M |
| December 31, 2012 | 549.96M |
| September 30, 2012 | 585.49M |
| June 30, 2012 | 601.05M |
| March 31, 2012 | 759.20M |
| December 31, 2011 | 759.77M |
| September 30, 2011 | 892.10M |
| Date | Value |
|---|---|
| June 30, 2011 | 991.17M |
| March 31, 2011 | 961.87M |
| December 31, 2010 | 934.65M |
| September 30, 2010 | 932.02M |
| June 30, 2010 | 825.18M |
| March 31, 2010 | 906.98M |
| December 31, 2009 | 1.015B |
| September 30, 2009 | 1.000B |
| June 30, 2009 | 982.80M |
| March 31, 2009 | 972.14M |
| December 31, 2008 | 994.41M |
| September 30, 2008 | 1.025B |
| June 30, 2008 | 1.187B |
| March 31, 2008 | 1.294B |
| December 31, 2007 | 1.229B |
| September 30, 2007 | |
| June 30, 2007 | 701.65M |
| March 31, 2007 | 704.96M |
| December 31, 2006 | 462.79M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 276.05M |
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.685B |
| Shareholders Equity (Quarterly) | 1.737B |